Status:
COMPLETED
Functional Brain Imaging in Recreational Users of Ecstasy
Lead Sponsor:
Hadassah Medical Organization
Conditions:
Amphetamine-Related Disorders
Eligibility:
All Genders
18-65 years
Brief Summary
Recreational use of "ecstasy" (MDMA; 3,4-methylenedioxymethamphetamine) is associated with long-lasting effects on metabolism in the human brain. The investigators propose to investigate whether chron...
Detailed Description
Recreational use of "ecstasy" (MDMA; 3, 4-Methylenedioxymethamphetamine) is associated with long-lasting effects on metabolism in the human brain. In particular, there is evidence of long-term damage ...
Eligibility Criteria
Inclusion
- Chronic users of ecstasy, and healthy controls, with no other diseases or drug abuse
Exclusion
- Pregnant and breast feeding women
- Aged below 18
- Neurological disorders
- Drug abuse
Key Trial Info
Start Date :
January 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2011
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT00254306
Start Date
January 1 2006
End Date
July 1 2011
Last Update
July 7 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dept. of Nuclear Medicine, Hadassah Hospital, Ein Kerem
Jerusalem, Israel, 91120